Gina Guzman, M.D., Promoted to Vice President and Chief Medical Director at Munich Re US (Life)

Normal view (turn off text only mode)
You are here:

12 January 2016

Gina Guzman, M.D., Promoted to Vice President and Chief Medical Director at Munich Re US (Life)

Atlanta, GA - January 12, 2016 

Munich Re, US (Life) announces the retirement of Mark Skillan, M.D., DABIM, vice president and chief medical director, after 31 years of service to the company and the life insurance industry. Gina C. Guzman, M.D., DABIM, FLMI, FALU, will be stepping into the role of vice president and chief medical director for Munich Re, US (Life), effective immediately.


Dr. Guzman is board certified in Internal Medicine and Insurance Medicine. She served as president of the American Academy of Insurance Medicine (AAIM) in 2013 and remains actively involved on the Executive Council. She currently serves on the Board of Insurance Medicine, the American Council of Life Insurers (ACLI) Medical Section Genetics Task Force and the 2016 ACLI Medical Section Planning Committee. She also served as president of the Midwestern Medical Directors Association in 2007 and is currently serving a second term as president of the organization for 2016. Dr. Guzman is an in-demand presenter at local, regional and national underwriting meetings in North America and she is an invited speaker for the 2016 ICLAM meeting in the Netherlands.


Bill Moore, vice president, underwriting and medical for Munich Re, US (Life) commented, “Over the past five years, Gina has clearly demonstrated an outstanding ability for managing increasing responsibilities. She is a talented manager and researcher, a strategic thinker and a valued contributor to the underwriting and medical management team.”


Dr. Guzman was responsible for the medical team’s content updates to EDGE, Munich Re’s online underwriting manual, including conducting mortality research on impairments and creating and delivering technical presentations to the industry on those impairments. An avid learner, Dr. Guzman earned her FLMI and FALU underwriting designations and was selected by her peers to be one of the youngest ever presidents of the AAIM, the premier US medical director professional organization. She also taught AAIM’s introductory course for new medical directors.


Dr. Guzman is now responsible for the oversight of the medical and underwriting actuarial functions for Munich Re US (Life) reporting to Bill Moore. She will continue to be based in Chicago. Dr. Skillan will continue his service as vice president throughout 2016. “Mark will be instrumental in assuring a smooth transition as Gina assumes her new responsibilities and we are all grateful for his continued dedication,” said Moore.


Note for the editorial staff:
For further questions please contact

Media Relations, Munich American Reassurance Company
Meaghan Kenagy
Tel.: 770-350-3222

Munich American Reassurance Company, (Munich Re US (Life)) founded in 1959, is one of the largest reinsurers in the U.S. offering life and disability reinsurance to insurance companies throughout the United States. The company also writes group, credit and other reinsurance products. Headquartered in Atlanta, with an office in Chicago, the company is licensed, accredited or authorized in all fifty states; Washington, D.C.; Guam; and Puerto Rico.


Munich Re stands for exceptional solution-based expertise, consistent risk management, financial stability and client proximity. This is how Munich Re creates value for clients, shareholders and staff. In the financial year 2014, the Group – which combines primary insurance and reinsurance under one roof – achieved a profit of €3.2bn on premium income of over €48bn. It operates in all lines of insurance, with over 43,000 employees throughout the world. With premium income of around €27bn from reinsurance alone, it is one of the world’s leading reinsurers. Especially when clients require solutions for complex risks, Munich Re is a much sought-after risk carrier. Its primary insurance operations are concentrated mainly in the ERGO Insurance Group, one of the leading insurance groups in Germany and Europe. ERGO is represented in over 30 countries worldwide and offers a comprehensive range of insurances, provision products and services. In 2014, ERGO posted premium income of €18bn. In international healthcare business, Munich Re pools its insurance and reinsurance operations, as well as related services, under the Munich Health brand. Munich Re’s global investments amounting to €227bn are managed by MEAG, which also makes its competence available to private and institutional investors outside the Group.




Disclaimer
This press release contains forward-looking statements that are based on current assumptions and forecasts of the management of Munich Re. Known and unknown risks, uncertainties and other factors could lead to material differences between the forward-looking statements given here and the actual development, in particular the results, financial situation and performance of our Company. The Company assumes no liability to update these forward-looking statements or to conform them to future events or developments.

Contact


Main Navigation
Service Men
Accessibility

© Copyright 2015 Munich American Reassurance Company. All Rights Reserved.

Note


This publication is available exclusively to Munich Re clients. Please contact your Client Manager.